Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-J Body

Showing results (191-200 of 213) with videos related to

Pageof 22
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 22, 2019
Bone health in childhood cancer: review of the literature and recommendations for the management of bone health in childhood cancer survivorsG Marcucci, G Beltrami, A Tamburini, et al.
Calcified Tissue International|March 22, 2017
Osteoporosis in Frail Patients: A Consensus Paper of the Belgian Bone ClubE Gielen, P Bergmann, O Bruyère, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 18, 2020
Bone health in cancer: ESMO Clinical Practice GuidelinesR Coleman, P Hadji, J-J Body, et al.
Calcified Tissue International|September 18, 2007
The use of bone markers in a 6-week study to assess the efficacy of oral clodronate in patients with metastatic bone diseaseJ E Brown, E V McCloskey, J A Dewar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Current use of bisphosphonates in oncology. International Bone and Cancer Study GroupJ J Body, R Bartl, P Burckhardt, et al.
British Journal of Cancer|January 1, 1997
Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemiaS H Ralston, D Thiébaud, Z Herrmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancyM Pecherstorfer, Z Herrmann, J J Body, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 1, 2020
Efficacy of teriparatide compared with risedronate on FRAX<sup>®</sup>-defined major osteoporotic fractures: results of the VERO clinical trialJ-J Body, F Marin, D L Kendler, et al.
Bone|September 2, 2020
Discriminating value of HR-pQCT for fractures in women with similar FRAX scores: A substudy of the FRISBEE cohortS I Cappelle, M Moreau, R Karmali, et al.
Calcified Tissue International|August 24, 2000
Do estrogens effectively prevent osteoporosis-related fractures? The Group for the Respect of Ethics and Excellence in ScienceJ Y Reginster, O Bruyere, M Audran, et al.
Pageof 22

Showing results (191-200 of 213) with videos related to

Sort By:
Pageof 22
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 22, 2019
Bone health in childhood cancer: review of the literature and recommendations for the management of bone health in childhood cancer survivorsG Marcucci, G Beltrami, A Tamburini, et al.
Calcified Tissue International|March 22, 2017
Osteoporosis in Frail Patients: A Consensus Paper of the Belgian Bone ClubE Gielen, P Bergmann, O Bruyère, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 18, 2020
Bone health in cancer: ESMO Clinical Practice GuidelinesR Coleman, P Hadji, J-J Body, et al.
Calcified Tissue International|September 18, 2007
The use of bone markers in a 6-week study to assess the efficacy of oral clodronate in patients with metastatic bone diseaseJ E Brown, E V McCloskey, J A Dewar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Current use of bisphosphonates in oncology. International Bone and Cancer Study GroupJ J Body, R Bartl, P Burckhardt, et al.
British Journal of Cancer|January 1, 1997
Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemiaS H Ralston, D Thiébaud, Z Herrmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancyM Pecherstorfer, Z Herrmann, J J Body, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 1, 2020
Efficacy of teriparatide compared with risedronate on FRAX<sup>®</sup>-defined major osteoporotic fractures: results of the VERO clinical trialJ-J Body, F Marin, D L Kendler, et al.
Bone|September 2, 2020
Discriminating value of HR-pQCT for fractures in women with similar FRAX scores: A substudy of the FRISBEE cohortS I Cappelle, M Moreau, R Karmali, et al.
Calcified Tissue International|August 24, 2000
Do estrogens effectively prevent osteoporosis-related fractures? The Group for the Respect of Ethics and Excellence in ScienceJ Y Reginster, O Bruyere, M Audran, et al.
Pageof 22